(Q51727427)

10 April 2018

title

Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. (English)

1 reference

10 April 2018

author name string

Takada T

1

1 reference

10 April 2018

Suzuki E

2

1 reference

10 April 2018

Ishida T

3

1 reference

10 April 2018

Moriyama H

4

1 reference

10 April 2018

Ooi H

5

1 reference

10 April 2018

Hasegawa T

6

1 reference

10 April 2018

Tsukuda H

7

1 reference

10 April 2018

Gejyo F

8

1 reference

10 April 2018

publication date

1 November 2001

1 reference

10 April 2018

published in

Tissue Antigens

1 reference

10 April 2018

volume

58

1 reference

10 April 2018

issue

5

1 reference

10 April 2018

page(s)

293-298

1 reference

10 April 2018

Chemokines in allergic inflammation

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

A polymorphism at position -403 in the human RANTES promoter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

A rare polymorphism at position -28 in the human RANTES promoter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

A single nucleotide polymorphism at position --109 of the RANTES proximal promoter

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

The source and role of RANTES in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

1 reference

7 January 2021

Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Clonal analysis of lung and blood T cells in patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Speculations on sarcoidosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.580502.X

7 January 2021

10.1034/J.1399-0039.2001.580502.X

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018